stores, and fatty acid metabolism. AEA was recently reported to block TASK-3 potassium channels thereby depolarizing membranes. Common inhibitors of TASK-3, Zn 2 þ , Ruthenium Red, and low pH mimicked the excitatory effects of AEA and NADA, suggesting that their effects on [Ca 2 þ ] i and transmitter levels may be attributable to membrane depolarization upon TASK-3 blockade. The K þ -evoked Ca 2 þ entry and Ca 2 þ -dependent transmitter release were inhibited by nanomolar concentrations of the CB 1 receptor agonist WIN55212-2; this action was sensitive to the selective CB 1 receptor antagonist AM251. However, in the low micromolar range, WIN55212-2, NADA and AEA inhibited the K þ -evoked Ca 2 þ entry and transmitter release independently of CB 1 receptors, possibly through direct Ca 2 þ channel blockade. Conclusions and implications: We report here for hybrid endocannabinoid/endovanilloid ligands novel dual functions which were qualitatively similar to activation of CB 1 or TRPV 1 receptors, but were mediated through interactions with different targets.
Introduction
A group of endogenous arachidonic acid derivatives, such as arachidonoylethanolamide (anandamide, AEA) and N-arachidonoyl dopamine (NADA), can activate both the cannabinoid type-1 receptor (CB 1 ) (Devane et al., 1992; Bisogno et al., 2000) and the transient release potential family vanilloid type-1 (TRPV 1 ) vanilloid receptor (van der Stelt and Di Marzo, 2004; Bradshaw and Walker, 2005) . These substances are therefore called hybrid endocannabinoid/ endovanilloid ligands.
The predominant neuronal cannabinoid receptor, the CB 1 receptor, is involved in several (patho)physiological mechanisms in the hippocampus. These include, for instance, modulation of spatial and short-term memory, seizure threshold or b-amyloid-induced pathophysiological changes (Lichtman and Martin, 1996; Mallet and Beninger, 1998; Wallace et al., 2002; Chen et al., 2003; Mazzola et al., 2003; Piomelli, 2003; Ramirez et al., 2005) . The widespread functional presence of CB 1 receptors in nerve terminals of the hippocampus has been well documented (Katona et al., 1999; Degroot et al., 2006; Kawamura et al., 2006) . Activation of the CB 1 receptor by its first discovered endogenous agonist AEA (Devane et al., 1992) and the recently discovered NADA (Bisogno et al., 2000) can induce a great diversity of intracellular responses, including the inhibition of Ca 2 þ channel opening which decreases transmitter release (Howlett et al., 2004) . TRPV 1 receptors are assumed to be present in the hippocampal neurons (Mezey et al., 2000; Roberts et al., 2004; Toth et al., 2005) . Activation of the TRPV 1 receptor causes Ca 2 þ and Na þ entry and neuronal depolarization.
Interestingly, only a few ex vivo studies have demonstrated a presumably presynaptic site of action for TRPV 1 receptors in the hippocampus. For instance, AEA and NADA were shown to increase paired-pulse depression, in a manner sensitive to TRPV 1 receptor antagonists (Al-Hayani et al., 2001; Huang et al., 2002) . This implies that the predominant effect of hybrid agonists might be excitation by presynaptic TRPV 1 receptor activation rather than inhibition by presynaptic CB 1 receptor activation. However, the predominant location of the TRPV 1 receptor, determined with immunohistochemistry, is more likely to be postsynaptic in the hippocampus (Toth et al., 2005; Cristino et al., 2006 ). This conclusion is strengthened by the observation that selective and potent agonists of the TRPV 1 receptor, such as capsaicin and resiniferatoxin, failed to induce Ca 2 þ entry and g-aminobutyric acid (GABA) release in hippocampal nerve terminals . Instead, E-and Z-capsaicin, and the TRPV 1 receptor antagonist iodoresiniferatoxin as well as the CB 1 receptor antagonist AM251 concentration-dependently inhibited the high K þ -induced Ca 2 þ entry and GABA release in hippocampal nerve terminals. Furthermore, iodoresiniferatoxin shifted the concentration-response curve of AM251 to the right but did not affect the size of maximal inhibition. These findings point toward a common site of action, such that ligands for the CB 1 receptor and the TRPV 1 receptor can directly modulate intracellular Ca 2 þ levels ([Ca 2 þ ] i ) via blocking voltage-gated Ca 2 þ channels (VGCCs).
These all are in agreement with the general notion that endocannabinoid and endovanilloid substances have additional targets (new putative receptors, ion channels) both in the hippocampus and in other brain areas (Pertwee, 2004; van der Stelt and Di Marzo, 2005; Oz, 2006) . For instance, we have shown earlier that cannabinoid ligands are able to inhibit the release of glutamate, evoked with a strong stimulation by high K þ , in the hippocampus and in the striatum, via CB 1 receptor-independent mechanisms (Köfalvi et al., 2003 (Köfalvi et al., , 2005 . However, this should not undermine the role of presynaptic CB 1 receptors in the control of excitatory synaptic transmission, which was recently emphasized by different groups (Kawamura et al., 2006; Takahashi and Castillo, 2006 
Methods

Preparation of synaptosomes
All studies were conducted in accordance with the principles and procedures outlined in the EU guidelines and were approved by the local Animal Care Committee of the Institute. All efforts were made to reduce the number of animals used and to minimize their suffering. Male Wistar rats, 140-160 g; Charles-River, Barcelona, Spain) were anesthetized with halothane before being decapitated.
For fluorimetric assay. A synaptosomal fraction of the hippocampi was prepared with slight modifications of the technique described by Köfalvi et al. (2006) . For each experiment, hippocampi from two rats were quickly removed into ice-cold sucrose solution (0.32 M, containing 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4) and were homogenized instantly with a Teflon homogenizer and centrifuged at 2000 g for 3 min. The supernatant was centrifuged at 13 000 g for 12 min. The mitochondria-free fraction of the pellet was collected and washed at 13 000 g for 2 min in sucrose solution at 41C, then decanted and stored in a sealed container on ice.
For [
3 H]GABA and [ 3 H]glutamate release assay. As described earlier (Köfalvi et al., 2005) , the removed hippocampi were rapidly dissected and were homogenized in ice-cold 0.32 M sucrose solution (containing 1 mM EDTA, 1 mg/ml bovine serum albumin and 5 mM HEPES, pH 7.4) at 41C and centrifuged at 2000 g for 10 min. The supernatant was centrifuged at 13 000 g for 12 min. The pellet was resuspended in ice-cold 45% (v/v) Percoll in Krebs solution (pH 7.4) and centrifuged at 13 000 g for 2 min to eliminate free mitochondria and glial debris. The top layer was washed twice at 13 000 g at 41C for 2 min in oxygenated Krebs solution of the following composition (in mM): NaCl 113, KCl 3, KH 2 PO 4 1.2, MgSO 4 1.2, CaCl 2 2.5, NaHCO 3 25, glucose 10, oxygenated with 95% O 2 and 5% CO 2 , pH 7.4.
Fluorimetric assay
Experiments were performed as described earlier : synaptosomal pellets (1 mg protein) were preincubated with Fura2/AM (5 mM) for 20 min at 251C in the incubation solution of the following composition: NaCl (132 mM), KCl (1 mM), MgCl 2 (1 mM), CaCl 2 (0.1 mM), H 3 PO 4 (1.2 mM), glucose (10 mM), HEPES (10 mM) and pH 7.4. Then the pellet was centrifuged at 13 000 g, washed and resuspended in 2 ml assay solution (NaCl (132 mM), KCl (3.1 mM), MgCl 2 (1.2 mM), CaCl 2 (2.5 mM), H 3 PO 4 (0.4 mM), glucose (10 mM), HEPES (10 mM), pH 7.4). The fluorescence was monitored at 371C, using a computer-assisted Spex Industries (Edison, NJ, USA) Fluoromax spectrofluorometer at 510 nm emission and double excitation at 340 and 380 nm, using 5 nm slits. After the 4-min stabilization period (T À240 -T 0 s), data were collected at 2 s intervals. The first 90 s (45 data points; T 0 -T 90 ) represented the pretreatment period, and then 2 ml of the stock drug solutions was applied. Two hundred and seventy seconds later (T 360 ), the synaptosomes were challenged with 20 ml of KCl solution (final concentration of 20 mM). The calibration was made using 5 mM ionomycin (R max ), at T 400 and 5 mM ethylene glycol bis(b-aminoethylether)-N,N,N',N',-tetraacetic acid (EGTA)/30 mM Tris, pH 9.6 (R min ), at T 500 . The fluorescence intensities were converted into [Ca 2 þ ] i values by using the calibration equation for double excitation wavelength measurements and taking the dissociation constant of the Fura-2/Ca 2 þ complex as 224 nM (Grynkiewicz et al., 1985) .
In calcium-free experiments, the synaptosomal pellet was incubated at room temperature in the assay medium for 5 min to allow the saturation of the intracellular stores, and then was washed twice in an assay medium of similar composition but without addition of CaCl 2 . All other steps were identical except that ionomycin was administered together with 5 ml of CaCl 2 (1 M, final concentration of 2.5 mM) to establish R max . In acidification experiments, HEPES (7.5 mM) and methanesulfonic acid (MES) (7.5 mM) were used in the assay solution as a dual buffer providing useful buffer range up to pH 5.5. NaCl was decreased to 127 mM to maintain the same osmolarity. The pH in the cuvette was checked by a microtip pH meter. was calculated as the greatest difference of the measured value from the extension of the latter predictive line. Every day, the first and the last synaptosomal samples were used to establish dimethylsulfoxide (DMSO) control values. Randomly, H 2 O controls (2 ml H 2 O into 2 ml assay volume, see Results section) were measured as an absolute control for DMSO (Figure 1d and e). ]glutamate release assays from hippocampal synaptosomes Experiments were performed with modifications of our previous studies (Köfalvi et al., 2003 (Köfalvi et al., , 2005 . The synaptosomes were diluted to 1 ml with Krebs solution, and equilibrated with careful oxygenation (95% O 2 and 5% CO 2 ) at 371C for 5 min, and after that 10 mCi of Piscataway, NJ, USA) were added to the synaptosomes for 5 min. All solutions contained the GABA transaminase and glutamate decarboxylase inhibitor, aminooxyacetic acid (100 mM). Aliquots (70 ml, 500 mg protein) of the preloaded synaptosomes were transferred into 70 ml perfusion chambers, and were trapped between two layers of Whatman GF/C filters and superfused continuously at a rate of 0.7 ml/min until the end of the experiment. Upon termination of the 20-min washout, 2-min samples were collected for liquid scintillation assay. All experimental procedures were performed at 371C. At the 6th and the 20th min of the sample collection period, release of transmitters was triggered twice (Figure 5e and f). The proportion of GABA and glutamate in the released radioactivity was confirmed to be 495%, as reported previously (Köfalvi et al., 2005) . Up to the highest concentrations used, none of the tested compounds affected significantly the photometric measurements at the wavelengths used. , Po0.01) (Figure 1a -e). However, using less than 2 ml of even more concentrated DMSO stock solutions would have had affected precision and drug solubility. As a positive drug control, epibatidine (100 nM; n ¼ 6) was added at T 90 , which caused a sustained [Ca (Yu et al., 1997) . In DDT 1 MF-2 smooth muscle cells, arachidonic acid activates a noncapacitive Ca 2 þ entry sensitive to Gd 3 þ (1 mM) (Demuth et al., 2005) . Thus, the effect of NADA and AEA might be, at least partly, mediated by their possible metabolite, arachidonic acid. For this purpose, we tested AEA and NADA in the presence of either PMSF (300 mM), a non-specific irreversible amidase inhibitor that also inhibits the action of FAAH (Desarnaud et al., 1995) , or DuP697 (100 nM), a selective COX-2 inhibitor (Gans et al., 1990) has already been tested in a previous study and also failed to change the resting [Ca 2 þ ] i .
Data treatment
Results
Fluorimetric experiments
The general pore blocker and TRPV channel subfamily antagonist Ruthenium Red (3 mM) (Hu et al., 2004) , and the selective TRPV 1 receptor antagonist SB366791 (3 mM) (Gunthorpe et al., 2004) as well as the CB 1 receptor antagonist AM251 (0.5 mM) (all from T À240 ) failed to counteract the [Ca 2 þ ] i rise, triggered by AEA (30 mM) and NADA (10 mM) (n ¼ 6-8; Figure 2a and b). n ¼ 6, ns), indicating that the effect of Ruthenium Red is independent from TRPV 1 receptor blockade. Ruthenium Red and AEA in the micromolar range have been shown to directly block TASK-3 background potassium channels (Maingret et al., 2001; Czirjak and Enyedi, 2003) and thus depolarize neuronal membranes and trigger Ca 2 þ entry.
To test this possibility in our system, we now applied Ruthenium Red (3 and 10 mM, n ¼ 6) from T 90 and found it to trigger a rapid, sustained, significant and concentrationdependent TASK-3 channels are also inhibited by acidic pH (Kim et al., 2000; Czirjak and Enyedi, 2003; Aller et al., 2005) . In our model, acidification triggered a sustained and significant [Ca 2 þ ] i rise with similar kinetics to those observed upon the application of AEA, NADA, Ruthenium Red or Zn 2 þ ( Figure   1d and e). At pH 6.5, the size of [Ca 2 þ ] i rise was similar to that triggered by NADA at 3 mM and to that triggered by AEA at 30 mM. At pH 5.5, the [Ca 2 þ ] i rise was slightly greater than that triggered by AEA at 100 mM, but this difference did not reach the level of statistical significance (Figure 1d and e). (Figure 3a and c). JWH133, up to the maximally CB 2 receptor-selective Figure 2 The AEA-(a) and NADA-(b) triggered rise in [Ca 2 þ ] i was only prevented by the absence of external Ca 2 þ , but not by inhibitors of the TRPV 1 , CB 1 or dopamine receptors, endocannabinoid-metabolizing enzymes FAAH and COX-2, the arachidonateregulated non-capacitative Ca 2 þ entry and intracellular storeoperated Ca 2 þ channels. Fluorimetric recordings were carried out as described in Figure 1 . Antagonists and modulators (SB, SB366791; RR, Ruthenium Red; AM, AM251; Sulp, sulpiride; DuP, DuP697; 2APB, 2-aminoethoxydiphenyl borate; PMSF, phenylmethylsulfonyl fluoride; + Ca 2 þ , Ca 2 þ -free) were applied at T À240 , that is 4 min before starting the recordings, and at T 90 , either DMSO, or DMSO þ AEA or NADA were applied. All data points are mean7 s.e.m. of nX6 observations, ***Po0.001, compared with respective controls of antagonists and modulators.
concentration of 1 mM, failed to alter the K þ -evoked Ca 2 þ entry (Figure 3a and c) . To exclude the possibility that any CB 2 receptors in our system were already under tonic activation, we tested the CB 2 receptor-selective antagonist AM630 (1 mM), which also failed to alter the K þ -evoked Ca 2 þ entry (Figure 3a and c) . entry by AEA and NADA (Figure 3d ). Higher concentrations of AM251 could not be tested since this AM251 is also a VGCC inhibitor with an IC 50 of 1.1 mM (Köfalvi et al., 2006) . þ -evoked Ca 2 þ entry and this was antagonized by AM251 (500 nM). The CB 2 receptor-selective agonist JWH133 (1 mM) and the CB 2 receptor-selective antagonist AM630 (1 mM) failed to alter the K þ -evoked Ca 2 þ . (d) Inhibitors of the TRPV 1 receptor (SB, SB366791, 3 mM and RR, Ruthenium Red, 3 mM); CB 1 receptor (AM, AM251, 500 nM); dopamine receptors (Sulp, sulpiride, 3 mM) endocannabinoid-metabolizing enzymes FAAH (PMSF, phenylmethylsulfonyl fluoride, 100 mM) and COX-2 (DuP, DuP697, 100 nM); the arachidonate-regulated non-capacitative Ca 2 þ -entry (Gd 3 þ , 1 mM), and intracellular store-operated Ca 2 þ channels (2APB, 2-aminoethoxydiphenyl borate, 3 mM) failed to reverse the inhibition of NADA and AEA on the K þ -evoked Ca 2 þ entry. Note that the modification of NADAand AEA-induced inhibition of the K þ -evoked Ca 2 þ entry was estimated by comparison to the respective controls, namely, DMSO þ antagonist alone. All data points represent mean7s.e.m. of nX6 observations. *Po0.05 and **Po0.01 vs respective control. # Po0.05; it indicates that the extent of inhibition is significantly different in the absence vs in the presence of the antagonist.
Bidirectional presynaptic actions of NADA and AEA A Köfalvi et al
Among the antagonists of the TRPV 1 receptors SB366791 (3 mM, T À240 ) per se had no effect on the evoked Ca 2 þ entry, whereas Ruthenium Red (3 mM, from T À240 ) inhibited it by 35% (Figure 3d ), perhaps reflecting this compound's blockade of VGCC (Tapia and Velasco, 1997) . When Ruthenium Red was applied from T 90 , it inhibited the K þ -evoked Ca 2 þ entry by 39.3% at 3 mM, and by 48.6% at 10 mM (n ¼ 6 and Po0.01 for each). SB366791 (3 mM) did not significantly alter the percentage of inhibition exerted by NADA and AEA (n ¼ 6 for each). Ruthenium Red also failed to prevent the inhibition caused by AEA and NADA (Figure 3d) . Moreover, Ruthenium Red did not add to the inhibition by AEA or NADA, even though it inhibited Ca 2 þ entry by itself (see above).
Another possibility was that the effect of NADA was mediated by the activation of inhibitory dopamine receptors by its possible metabolite, dopamine. However, sulpiride (from T À240 ) at 3 mM, which concentration is enough to block D 2 , D 3 and D 4 receptors, failed to prevent the inhibition of K þ -evoked Ca 2 þ entry (n ¼ 6; Figure 3d ) as well as the NADA-evoked Ca 2 þ entry ( Figure 2b ). Sulpiride had no effect either on the K þ -evoked Ca 2 þ entry (n ¼ 6; Figure 3d) ]glutamate in a concentration-dependent and biphasic fashion, leaving the resting release of the transmitters unaffected. In case of GABA, a plateau effect was observed up to 1 mM WIN55212-2 and, above 1 mM, a second phase of inhibition was detected (Figure 4c ). AM251 (500 nM) fully antagonized the effect of WIN55212-2 (100 nM-1 mM), but failed to affect the inhibitory effect of higher concentrations of WIN55212-2 (Figure 4c ). For glutamate, the plateau effect was observed up to 3 mM of WIN55212-2 and a second phase of inhibition appeared at concentrations of WIN55212-2 above 3 mM (Figure 4d) . Again, AM251 (500 nM) fully antagonized the inhibition by WIN55212-2 up to 3 mM of the agonist but not the second phase of inhibition caused by higher concentrations of WIN55212-2 (Figure 4d) .
As concentrations higher than 500 nM of the competitive antagonist AM251 might be required to counteract the effect of WIN55212-2 in the micromolar range, we tested AM251 at 5 mM against 10 mM WIN55212-2 (since 0.5 mM AM251 abolished the inhibitory action of 1 mM WIN55212-2). We know that AM251 inhibits Ca 2 þ entry and transmitter releases in the hippocampus and striatum with IC 50 values of 1-3 mM (Köfalvi et al., 2003 (Köfalvi et al., , 2005 (Figure 4e and f) . Altogether, these findings indicate that the effect of WIN55212-2 in the micromolar range is CB 1 receptor-independent, and is likely to be owing to direct VGCC blockade (Shen and Thayer, 1998) . Therefore, we determined the EC 50 values for WIN55212-2 by choosing the maximum selective concentrations as 1 mM for GABA release (EC 50 , 59.8 nM; 95% confidence interval: 51.2-67.4 nM) and 3 mM for glutamate release (EC 50 , 63.1 nM; 42.5-91.1 nM; Figure 4a- , and after 20 min of washout, 2-min samples were collected and counted for tritium, which is expressed as fractional release % (FR%). The synaptosomes were stimulated twice with 20 mM K þ , as indicated by S 1 and S 2 . WIN55212-2 (WIN) and AM251 (500 nM) were applied as indicated by the horizontal bar. (c and d) Concentration-response curves for WIN55212-2 in the absence and in the presence of AM251 (500 nM). S 2 /S 1 values of controls were taken as 100%. Note that the curves were fitted only to those concentrations of WIN55212-2, which displayed no significant difference from control in the presence of AM251. (e and f) AM251 even at the concentration of 5 mM, failed to counteract the inhibition by WIN55212-2 (10 mM) of the evoked release of [ 3 H]GABA (e) and [ 3 H]glutamate (f). Note that the scale of the y-axis is lower in e and f, in the presence of AM251 (5 mM), compared with its absence (see a and b), reflecting inhibition of Ca 2 þ entry by AM251, which is reflected by a lower K þ -evoked release of both transmitters. All data points represent mean7s.e.m. of n ¼ 12, *Po0.05, compared with control (CTRL).
Bidirectional presynaptic actions of NADA and AEA A Köfalvi et al and f). These observations in the transmitter release experiments are in parallel with effects of NADA and AEA in the Ca 2 þ measurement study. (Figure 5g-i) .
Discussion
Using our well-established pharmacological tools for the direct study of presynaptic neuromodulation (Katona et al., 1999; Köfalvi et al., 2003 Köfalvi et al., , 2005 Köfalvi et al., , 2006 As a previous study reported that NADA (50 mM) and micromolar 2APB caused sustained Ca 2 þ entry via TRPV 1 receptor activation in expression systems, which was sensitive to Ruthenium Red (3 mM) (Hu et al., 2004) , we investigated this possibility in our system.
Cannabinoid, vanilloid and dopamine receptors and rapid metabolism were not involved in the observed effects of NADA and AEA Endocannabinoid/endovanilloid ligands can induce Ca 2 þ entry through the TRPV 1 receptor (van der Stelt and Di Marzo, 2004) . In our case, 2APB (which potentiates responses at the TRPV 1 receptor Hu et al., 2004) , the TRPV 1 receptor antagonist SB366791 and the general TRPV receptor antagonist, Ruthenium Red, all failed to modulate the Ca 2 þ entry triggered by NADA and AEA. Accordingly, SB366791 also failed to antagonize transmitter release triggered by NADA and AEA. This indicates that ion channels, other than the TRP family channels, are involved in the observed effects of NADA and AEA. The reason for the virtual lack of TRPV 1 receptor function in hippocampal nerve terminals is detailed elsewhere and may be a consequence of the preferential post-synaptic location of the TRPV 1 receptor in the hippocampus (Toth et al., 2005; Cristino et al., 2006) . Additionally, one can note that putative TRPV 1 Rs in our system were not under an endogenous tone, as shown by the lack of effect of SB366791 per se. Although NADA and AEA are partial agonists for the CB 1 receptor and the CB 2 receptor, the non-selective CB 1 receptor/CB 2 receptor agonist WIN55212-2 as well as the CB 2 receptor agonist JWH133 failed to modulate the resting [Ca 2 þ ] i , indicating that the effect of AEA and NADA were not mediated by these receptors. NADA and AEA immediately triggered Ca 2 þ entry and this absence of lag in their effect argues against the involvement of a metabolic step. The lack of modulation of the effects of AEA and NADA by inhibitors of FAAH and COX-2 provided further evidence that metabolism of these compounds was not relevant to their activity here.
The arachidonate-regulated Ca 2 þ current (I ARC )
Recently, a novel mechanism for arachidonic acid-evoked Ca 2 þ entry has been described. This, the so-called 'noncapacitative Ca 2 þ entry channel,' through which arachidonic acid mediates Ca 2 þ influx, has been described in different cell types (Mignen and Shuttleworth, 2000; Fiorio Pla and Munaron, 2001 ). However, a known inhibitor of I ARC , Gd 3 þ (1 mM) (Demuth et al., 2005) , also failed to prevent NADA and AEA from triggering Ca 2 þ entry. Therefore, we have concluded that the arachidonic acid derivatives NADA and AEA did not induce significant I ARC in our model.
Blockade of TASK-3 K þ channels as a plausible explanation for the underlying mechanism TASK-1 and TASK-3 are background, two pore domain, outward K þ channels, which maintain the resting membrane potential, and are expressed in neurons (Callahan et al., 2004; Aller et al., 2005) . TASK-3 is widely expressed in the hippocampus, whereas TASK-1 displays a restricted expression in the brain (Kim et al., 2000; Aller et al., 2005) . Their functional relevance is illustrated by the ability of halothane to potentiate TASK currents, leading to hyperpolarization of neurons, which contributes to its general anesthetic action. A recent study has demonstrated that AEA in the low micromolar range fully blocks TASK-1 and partially inhibits TASK-3 channels (Maingret et al., 2001) . Assuming that AEA and its structural analogue NADA blocked TASK-1 and/or TASK-3 channels in our model, it is relatively easy to explain how the two ligands depolarized the plasma membrane and triggered Ca 2 þ entry. However, it is hard to directly test this hypothesis, since AEA and NADA are expected to function as channel blockers. Therefore, other modulators of TASK channels would fail to reverse their blockade. Our attempt to inhibit the AEA-and NADAtriggered Ca 2 þ entry with co-administration of halothane (9.4 mM) was not successful (n ¼ 3 both for NADA and AEA, data not shown). This is in agreement with the findings of Maingret et al. (2001) , who showed that micromolar AEA almost completely abolished the millimolar halothaneinduced outward currents. We observed that AEA triggered small but already significant Ca 2 þ entry at 3 mM and the TASK-3 antagonist, Ruthenium Red (Czirjak and Enyedi, 2003) also elevated [Ca 2 þ ] i . These two findings point toward a possible involvement of TASK-3 rather than TASK-1. Zn 2 þ has been reported to be a less potent TASK-3 blocker than Ruthenium Red, developing its blockade over the micromolar concentration range (Clarke et al., 2004) . In our study, Zn 2 þ also triggered Ca 2 þ entry and the release of the transmitters with efficacy and potency similar to those of the weak TASK-3 antagonist, AEA. Furthermore, WIN55212-2 has been shown to inhibit TASK-1, but not TASK-3 channels (Maingret et al., 2001) and, in our study, this substance was devoid of effect on the resting levels of Ca 2 þ and transmitter release. Assuming that both Ruthenium Red and AEA or NADA acted through TASK-3 channels, in the experiments summarized in Figure 2a and b, some modulation of each other's effects might have been expected. The lack of such interaction might be explained by the fact that none of the three drugs were tested at maximal concentrations and therefore the [Ca 2 þ ] i in the presence of Ruthenium Red (3 mM) -taken as a baseline -still could have been surmounted with extra Ca 2 þ entry triggered by AEA or NADA. An interesting functional similarity between the TRPV 1 receptor and the TASK-3 channel is that both interact with AEA, Ruthenium Red and protons. The net result of these interactions is expected to be membrane depolarization and Ca 2 þ entry. In fact, acidification has been demonstrated to inhibit TASK-3 channels (Kim et al., 2000; Czirjak and Enyedi, 2003; Aller et al., 2005) and, consequently, to inhibit hyperpolarizing leak K þ conductance in cerebellar granule cells in culture (Lauritzen et al., 2003) and in thalamic relay neurons (Meuth et al., 2006) . It is important to note that the TASK-1 channels were almost fully inhibited in the pH 7.4-6.5 ranges, whereas TASK-3 channels needed greater shift towards acidic pH to become fully blocked. As mentioned above, we could not demonstrate functional presynaptic hippocampal TRPV 1 receptors in the same pharmacological assays previously , but we were able, in the present work, to show that acidification still triggered Ca 2 þ entry, suggesting that TASK type channels were functioning in our model. Further, our findings that acidification to pH 5.6 evoked twice as much Ca 2 þ entry as exposure to pH 6.5, indicated the involvement of TASK-3, rather than TASK-1 channels. Altogether, TASK-3 channels are present in hippocampal neurons and their blockade is expected to depolarize membranes and trigger Ca 2 þ entry. In our model, known potent or weaker inhibitors of the TASK-3 channels, such as AEA, Ruthenium Red, Zn 2 þ and protons, all triggered similar Ca 2 þ entries, in concentration ranges described for the entry and the release of transmitters. However, in the micromolar range, WIN55212-2 did inhibit the evoked release of GABA and glutamate in a CB 1 receptor-independent manner, very likely via direct VGCC blockade. This is in agreement with the findings of Shen and Thayer (1998) , who proposed that WIN55212-2 directly blocks N-and P/Q-type VGCCs above 1 mM, thus masking the indirect, CB 1 receptor-mediated, inhibition of VGCCs. Furthermore, this resolves the apparent conflict on the release of glutamate between our previous data and those of Takahashi and Castillo (2006) and of Kawamura et al. (2006) . Specifically, previously (Köfalvi et al., 2003 (Köfalvi et al., , 2005 we used much longer (six times) stimulation with 30 mM K þ to evoke glutamate release and this did not allow the observation of the CB 1 receptor-mediated modulation of release by WIN55212-2 in the nanomolar range. In the present series of experiments by using a more subtle, approximately 10-fold lower, stimulus which allows the detection of G protein-mediated presynaptic modulations (Ciruela et al., 2006) , we were able to demonstrate that CB 1 receptors did control the release of glutamate and that the previously proposed CB 3 receptors are likely to correspond to actions exerted directly on VGCCs. NADA and AEA are partial agonists of the CB 1 receptor and are much less potent than the full agonist WIN55212-2, but the maximal inhibitory effects (E max ) of NADA and AEA on the K þ -evoked responses were larger than the E max of WIN55212-2 (p1 mM). Therefore, CB 1 receptors are unlikely to be solely involved in the inhibitory action of NADA and AEA. Accordingly, CB 1 receptor blockade failed to prevent the inhibitory actions of NADA and AEA on the K þ -evoked responses. The inhibition was also unaffected by the blockade of TRPV 1 receptors and dopamine receptors as well. AM251 alone also failed to modify the K þ -evoked Ca 2 þ entry, excluding the possibility that CB 1 receptors were under tonic activation during depolarization, which might have offset the CB 1 receptor-mediated effects of WIN55212-2, NADA and AEA. Several ligands for the TRPV 1 receptor and CB 1 receptor have been shown to block voltage-and ligand-gated ion channels at low micromolar concentration. For instance, capsaicin, AEA, capsazepine, Ruthenium Red, AM404, AM251, SR141716A (Rimonabant) and WIN55212-2 block one or more of the Na þ , Ca 2 þ , K þ channels as well as 5-HT 3 and a7 nicotinic acetylcholine receptors (Shen and Thayer, 1998; White and Hiley, 1998; Kelley and Thayer, 2004; van der Stelt and Di Marzo, 2005; Köfalvi et al., 2006; Oz, 2006) . In the present study, the high-efficacy agonist WIN55212-2 was able to inhibit transmitter release in the low nanomolar range via activation of CB 1 receptors, whereas the low affinity/partial agonist NADA and AEA might only activate CB 1 receptors in a higher concentration range in which they already directly block VGCCs as well. Our finding that PMSF halved the inhibitory effect of AEA, suggested that a metabolite of AEA, generated by FAAH, also contributed to the inhibitory effect of AEA. Such effects could not be observed for NADA because NADA is also a FAAH inhibitor by itself (Bisogno et al., 2000) . Our data also shed light on the mechanisms by which NADA and AEA affected the evoked release of GABA and glutamate with different potency. This could be because the different subtypes of VGCCs contributing to the depolarization-induced glutamate release were more sensitive to AEA and NADA than the VGCCs in GABAergic terminals.
Conclusions
For the first time with tools that allow the direct study of presynaptic mechanisms, we have demonstrated that AEA and NADA produced opposite effects on Ca 2 þ entry under depolarizing and non-depolarizing conditions. Furthermore, these effects may not necessarily result from the activation of TRPV 1 and CB 1 receptors. Further studies are required to understand the physiological and pathological significance of these findings. For instance, AEA has been shown to be neurotoxic and induce apoptosis of certain cells, but the underlying mechanisms are very complex and often controversial (Maccarrone and Finazzi-Agro, 2003) . Presumably, AEA (and NADA) may kill a neuron simply with a massive depolarization if the cell expresses TASK-3. But the opposite is also possible: TASK-3 leak conductance has been shown to kill cerebellar granule cells; therefore, all compounds that block TASK-3 should prevent this type of cell death (Lauritzen et al., 2003) . Both AEA and NADA can accumulate in excess under depolarizing pathological conditions, such as epilepsy and stroke, and they may either exacerbate or inhibit calcium entry and release of glutamate, providing excellent therapeutic targets.
